Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Mostrar otras versiones (1)

Multiple myeloma (MM) is a heterogeneous disease with high-risk patients progressing rapidly despite treatment. Various definitions of high-risk MM are used and we reported that gene expression profile (GEP)-defined high risk was a major predictor of relapse. In spite of our best efforts, the majori...

Descripción completa

Detalles Bibliográficos
Autores principales: Jethava, Y, Mitchell, A, Zangari, M, Waheed, S, Schinke, C, Thanendrarajan, S, Sawyer, J, Alapat, D, Tian, E, Stein, C, Khan, R, Heuck, C J, Petty, N, Avery, D, Steward, D, Smith, R, Bailey, C, Epstein, J, Yaccoby, S, Hoering, A, Crowley, J, Morgan, G, Barlogie, B, van Rhee, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030385/
https://www.ncbi.nlm.nih.gov/pubmed/27471869
http://dx.doi.org/10.1038/bcj.2016.64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030385/
https://www.ncbi.nlm.nih.gov/pubmed/27471869
http://dx.doi.org/10.1038/bcj.2016.64

Ejemplares similares